Cargando…

Molecular characterization of multi drug resistant Escherichia coli isolates at a tertiary hospital in Abuja, Nigeria

Infections caused by multi-drug resistant Escherichia coli cause significant morbidity and mortality especially in developing countries. In this study, we describe the molecular characteristics of E. coli isolated from clinical specimens and the patients’ outcomes. Phenotypic methods were used in th...

Descripción completa

Detalles Bibliográficos
Autores principales: Medugu, Nubwa, Aworh, Mabel Kamweli, Iregbu, Kenneth, Nwajiobi-Princewill, Philip, Abdulraheem, Khadija, Hull, Dawn M., Harden, Lyndy, Singh, Pallavi, Obaro, Stephen, Egwuenu, Abiodun, Thakur, Siddhartha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9437016/
https://www.ncbi.nlm.nih.gov/pubmed/36050365
http://dx.doi.org/10.1038/s41598-022-19289-z
_version_ 1784781501953474560
author Medugu, Nubwa
Aworh, Mabel Kamweli
Iregbu, Kenneth
Nwajiobi-Princewill, Philip
Abdulraheem, Khadija
Hull, Dawn M.
Harden, Lyndy
Singh, Pallavi
Obaro, Stephen
Egwuenu, Abiodun
Thakur, Siddhartha
author_facet Medugu, Nubwa
Aworh, Mabel Kamweli
Iregbu, Kenneth
Nwajiobi-Princewill, Philip
Abdulraheem, Khadija
Hull, Dawn M.
Harden, Lyndy
Singh, Pallavi
Obaro, Stephen
Egwuenu, Abiodun
Thakur, Siddhartha
author_sort Medugu, Nubwa
collection PubMed
description Infections caused by multi-drug resistant Escherichia coli cause significant morbidity and mortality especially in developing countries. In this study, we describe the molecular characteristics of E. coli isolated from clinical specimens and the patients’ outcomes. Phenotypic methods were used in the identification and antimicrobial susceptibility testing of E. coli from clinical specimens from a tertiary hospital in Abuja, Nigeria. Whole genome sequencing was used to describe the antimicrobial resistance genes, serotypes, sequence types/clonal complexes, and mobile genetic elements. The mean age of the patients was 20.3 years with 70.1% females and majority of isolates 75% from urine, 21% from blood cultures, and 3% each from cerebrospinal fluid and endo-cervical swabs. Of the 107 non-duplicate E. coli isolates, 101 (94.3%) were resistant to ampicillin, 95 (88.8%) to trimethoprim/sulfamethoxazole, 86 (80.4%) to ceftriaxone, 60 (56.1%) to gentamicin, and eight (7.5%) to meropenem. There were 102 (95.3%) isolates that were multi-drug resistant (MDR). Expression of Extended Spectrum Beta Lactamase (ESBL) phenotype was detected in 54 (50%) and bla(CTX-M-15) genes detected in 75 (70.1%) isolates. The carbapenemase genes bla(NDM-1) and bla(NDM-5) were detected in six (5.6%), while the AmpC gene- bla(CMY-2), was detected in seven (6.5%) isolates. Two (1.9%) isolates simultaneously harboured the bla(OXA-1), bla(CMY-2), bla(CTX-M-15), and bla(NDM-5) genes. In total, 35 sequence types (STs) were found with the majority being ST131 (n = 23; 21.5%). The most common serotype was O25:H4 associated with all 23 strains of ST131, followed by O1:H6/ST648 (n = 6). The ST410, ST671, and ST101 strains displayed phenotypic resistance to wide array of antibiotic classes and harbored high numbers of antibiotic resistance genes via in-silico analysis. The ST410 strain in particular harbored a higher number of antibiotic resistance genes and was phenotypically resistant to a wider array of antibiotics. Four pairs of isolates were closely related with three isolates (ST131, ST38, ST652) having a pairwise SNP difference of zero. 71/72 75/76 52/14. The MDR E. coli lineages circulating in this setting pose a clinical and public health threat as they can hinder effective prevention and management of infections. The genetic diversity and MDR E. coli with the emergence of ST410 and ST101 clones is concerning because of the potential for rapid dissemination in hospitals and communities- further increasing the problems of antibiotic resistance. Continuous routine surveillance of E. coli infections for AMR in hospitals becomes imperative, aimed at development of effective antimicrobial stewardship programs, facilitating prudent use of antimicrobial agents, and limiting dissemination of resistant strains.
format Online
Article
Text
id pubmed-9437016
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-94370162022-09-03 Molecular characterization of multi drug resistant Escherichia coli isolates at a tertiary hospital in Abuja, Nigeria Medugu, Nubwa Aworh, Mabel Kamweli Iregbu, Kenneth Nwajiobi-Princewill, Philip Abdulraheem, Khadija Hull, Dawn M. Harden, Lyndy Singh, Pallavi Obaro, Stephen Egwuenu, Abiodun Thakur, Siddhartha Sci Rep Article Infections caused by multi-drug resistant Escherichia coli cause significant morbidity and mortality especially in developing countries. In this study, we describe the molecular characteristics of E. coli isolated from clinical specimens and the patients’ outcomes. Phenotypic methods were used in the identification and antimicrobial susceptibility testing of E. coli from clinical specimens from a tertiary hospital in Abuja, Nigeria. Whole genome sequencing was used to describe the antimicrobial resistance genes, serotypes, sequence types/clonal complexes, and mobile genetic elements. The mean age of the patients was 20.3 years with 70.1% females and majority of isolates 75% from urine, 21% from blood cultures, and 3% each from cerebrospinal fluid and endo-cervical swabs. Of the 107 non-duplicate E. coli isolates, 101 (94.3%) were resistant to ampicillin, 95 (88.8%) to trimethoprim/sulfamethoxazole, 86 (80.4%) to ceftriaxone, 60 (56.1%) to gentamicin, and eight (7.5%) to meropenem. There were 102 (95.3%) isolates that were multi-drug resistant (MDR). Expression of Extended Spectrum Beta Lactamase (ESBL) phenotype was detected in 54 (50%) and bla(CTX-M-15) genes detected in 75 (70.1%) isolates. The carbapenemase genes bla(NDM-1) and bla(NDM-5) were detected in six (5.6%), while the AmpC gene- bla(CMY-2), was detected in seven (6.5%) isolates. Two (1.9%) isolates simultaneously harboured the bla(OXA-1), bla(CMY-2), bla(CTX-M-15), and bla(NDM-5) genes. In total, 35 sequence types (STs) were found with the majority being ST131 (n = 23; 21.5%). The most common serotype was O25:H4 associated with all 23 strains of ST131, followed by O1:H6/ST648 (n = 6). The ST410, ST671, and ST101 strains displayed phenotypic resistance to wide array of antibiotic classes and harbored high numbers of antibiotic resistance genes via in-silico analysis. The ST410 strain in particular harbored a higher number of antibiotic resistance genes and was phenotypically resistant to a wider array of antibiotics. Four pairs of isolates were closely related with three isolates (ST131, ST38, ST652) having a pairwise SNP difference of zero. 71/72 75/76 52/14. The MDR E. coli lineages circulating in this setting pose a clinical and public health threat as they can hinder effective prevention and management of infections. The genetic diversity and MDR E. coli with the emergence of ST410 and ST101 clones is concerning because of the potential for rapid dissemination in hospitals and communities- further increasing the problems of antibiotic resistance. Continuous routine surveillance of E. coli infections for AMR in hospitals becomes imperative, aimed at development of effective antimicrobial stewardship programs, facilitating prudent use of antimicrobial agents, and limiting dissemination of resistant strains. Nature Publishing Group UK 2022-09-01 /pmc/articles/PMC9437016/ /pubmed/36050365 http://dx.doi.org/10.1038/s41598-022-19289-z Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Medugu, Nubwa
Aworh, Mabel Kamweli
Iregbu, Kenneth
Nwajiobi-Princewill, Philip
Abdulraheem, Khadija
Hull, Dawn M.
Harden, Lyndy
Singh, Pallavi
Obaro, Stephen
Egwuenu, Abiodun
Thakur, Siddhartha
Molecular characterization of multi drug resistant Escherichia coli isolates at a tertiary hospital in Abuja, Nigeria
title Molecular characterization of multi drug resistant Escherichia coli isolates at a tertiary hospital in Abuja, Nigeria
title_full Molecular characterization of multi drug resistant Escherichia coli isolates at a tertiary hospital in Abuja, Nigeria
title_fullStr Molecular characterization of multi drug resistant Escherichia coli isolates at a tertiary hospital in Abuja, Nigeria
title_full_unstemmed Molecular characterization of multi drug resistant Escherichia coli isolates at a tertiary hospital in Abuja, Nigeria
title_short Molecular characterization of multi drug resistant Escherichia coli isolates at a tertiary hospital in Abuja, Nigeria
title_sort molecular characterization of multi drug resistant escherichia coli isolates at a tertiary hospital in abuja, nigeria
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9437016/
https://www.ncbi.nlm.nih.gov/pubmed/36050365
http://dx.doi.org/10.1038/s41598-022-19289-z
work_keys_str_mv AT medugunubwa molecularcharacterizationofmultidrugresistantescherichiacoliisolatesatatertiaryhospitalinabujanigeria
AT aworhmabelkamweli molecularcharacterizationofmultidrugresistantescherichiacoliisolatesatatertiaryhospitalinabujanigeria
AT iregbukenneth molecularcharacterizationofmultidrugresistantescherichiacoliisolatesatatertiaryhospitalinabujanigeria
AT nwajiobiprincewillphilip molecularcharacterizationofmultidrugresistantescherichiacoliisolatesatatertiaryhospitalinabujanigeria
AT abdulraheemkhadija molecularcharacterizationofmultidrugresistantescherichiacoliisolatesatatertiaryhospitalinabujanigeria
AT hulldawnm molecularcharacterizationofmultidrugresistantescherichiacoliisolatesatatertiaryhospitalinabujanigeria
AT hardenlyndy molecularcharacterizationofmultidrugresistantescherichiacoliisolatesatatertiaryhospitalinabujanigeria
AT singhpallavi molecularcharacterizationofmultidrugresistantescherichiacoliisolatesatatertiaryhospitalinabujanigeria
AT obarostephen molecularcharacterizationofmultidrugresistantescherichiacoliisolatesatatertiaryhospitalinabujanigeria
AT egwuenuabiodun molecularcharacterizationofmultidrugresistantescherichiacoliisolatesatatertiaryhospitalinabujanigeria
AT thakursiddhartha molecularcharacterizationofmultidrugresistantescherichiacoliisolatesatatertiaryhospitalinabujanigeria